211 related articles for article (PubMed ID: 9348576)
1. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Colevas AD
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
González-Larriba JL; Garcia Carbonero I; Sastre Valera J; Perez Segura P; Diaz-Rubio E
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):90-7. PubMed ID: 9348577
[TBL] [Abstract][Full Text] [Related]
3. UFT plus carboplatin for head and neck cancer.
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Tomita T; Yamashita T
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):72-5. PubMed ID: 11098499
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
5. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
8. [Comparative clinical studies for head and neck cancer in Japan].
Fujii M
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1502-8. PubMed ID: 12355935
[TBL] [Abstract][Full Text] [Related]
9. UFT in gastric cancer: current status and future developments.
Hanauske AR
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):113-8. PubMed ID: 9348582
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():144-9. PubMed ID: 16897991
[TBL] [Abstract][Full Text] [Related]
11. [Head and neck cancer].
Inuyama Y; Fukuda S; Fujii M; Tanaka K; Kawaura M; Kawasaki K; Kohno N
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1136-42. PubMed ID: 8751800
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Taguchi T
Acta Otolaryngol; 2007 Oct; 127(10):1099-104. PubMed ID: 17851890
[TBL] [Abstract][Full Text] [Related]
13. Experience with UFT in Japan.
Taguchi T
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):30-4. PubMed ID: 9348564
[TBL] [Abstract][Full Text] [Related]
14. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
Posner MR
Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
[TBL] [Abstract][Full Text] [Related]
15. [A case in which palatal squamous cell carcinoma responded to UFT therapy].
Matsumoto T; Teramura C; Iida S; Tanaka A; Ashida H; Kimura J
Gan To Kagaku Ryoho; 1999 Mar; 26(4):523-5. PubMed ID: 10097750
[TBL] [Abstract][Full Text] [Related]
16. The role of chemotherapy in the treatment of head and neck cancer.
Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
[No Abstract] [Full Text] [Related]
17. [A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
Iwasaki K; Oida I; Usami A; Hashimoto Y; Yamada M; Ozawa T
Gan To Kagaku Ryoho; 1999 Feb; 26(3):369-72. PubMed ID: 10065103
[TBL] [Abstract][Full Text] [Related]
18. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
19. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Nishimura G; Yanoma S; Mizuno H; Satake K; Taguchi T; Ikeda Y; Tsukuda M
Cancer Lett; 2000 Oct; 159(1):1-7. PubMed ID: 10974399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]